Enter the first few characters of Company and click 'Go'
Ajanta Pharma Ltd. Company History and Annual Growth Details
2005 -Max Healthcare to establish India`s first brain lab in New Delhi -Max India Ltd Max telecom ventures Ltd signed a MoU
2008 -Max India signs agreement with UK firm for health insurance biz
2012 -Board declares Interim Dividend of 500% i.e. Rs. 10/- for every equity share of Rs. 2/- each to the shareholders. -Ajanta Pharma Ltd has splits its face value from Rs 10/- to 5/-
2013 - Board recommends Final Dividend 610% amounting to Rs. 12.20 per equity share of Rs. 2/- each to the shareholders. -Ajanta Pharma has announces bonus in the ratio of 1:2
2014 -Board recommends Final Dividendof 90%, i.e., Rs. 1.80 for every equity share of Rs. 2/- each to the shareholders
2015 -Ajanta Pharma Announces the Launch of Montelukast Sodium Oral Granules -Launch of Montelukast lR Tablets and Montelukast Chewable Tablets in US market -Fortune India presents award to Ajanta Pharma -Ajanta Pharma gets approvals for 3 ANDA's -Ajanta Pharma has splits its face value from Rs. 5 to Rs. 2